The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced but targeted innovation. In support of its mission, the IMAT program utilizes a variety of investigator-initiated research project grant mechanisms while retaining a strong commitment to diversity and to the training of scientists and clinicians in cross-cutting, research-enabling disciplines.
The NCI has approved reissuance for funding opportunity announcements through calendar year (CY) 2016. Please use the links below to navigate to currently open funding opportunities.
Funding opportunities in technology development are intended to support the inception, maturation, and subsequent dissemination of technically innovative and potentially transformative emerging technologies. These opportunities exist in parallel with various educational and training programs aimed at the recruitment, retention, and promotion of a diverse pool of talent in areas of emerging technology.
Next FY16 IMAT application due date is set for Feb. 26, 2016. See Funding Opportunities for more information.
Small business innovators should consider participating in the National SBIR/STTR conference in Washington DC on May 23-25, 2016, to learn how to engage Federal programs designed to support the commercialization of technological innovations. Consider showcasing your innovations at this broadly attended forum (applications due Feb 5, 2016).
The NCI has issued two new funding opportunities assocated with the Cancer Systems Biology Consortium. Please click the following announcement links for details: Research Centers for Cancer Systems Biology Consortium (U54); Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network (U24).
NCI has issued 4 new grant solicitations for highly innovative informatics technology development research under the Informatics Technologies for Cancer Research program. Various receipt deadlines starting in November, 2015. Please follow this link for more information.
Funding opportunity for Innovative Research in Cancer Nanotechnology
The NCI has a funding opportunity for Innovative Research in Cancer Nanotechnology (IRCN). more+
The Innovative Molecular Analysis Technologies Development for Cancer Research and Clinical Care (IMAT-SBIR, PAR-13-327) funding opportunity provides to small businesses conducting research towards the commercial development of emerging molecular and/or cellular analytical technologies intended for cancer detection and/or characterization. more +
TGen and Ceres Nanosciences announce collaboration to develop high-throughput Nanotrap enrichment methods for Mass Spectrometry (June 2014) more +
IMAT support leads to new commercial glycan tagging kit from Cambridge Isotope Laboratories.
Congratulations to the Muddiman group (NCSU) for commercial launch of their INLIGHTTM glycan tagging kit, an important new tool for enabling mass spectrometry-based glycomics research. more +